Sonnet BioTherapeutics Holdings, Inc. (SONN): Price and Financial Metrics
SONN Price/Volume Stats
| Current price | $2.02 | 52-week high | $18.72 |
| Prev. close | $2.41 | 52-week low | $1.97 |
| Day low | $1.97 | Volume | 874,920 |
| Day high | $2.73 | Avg. volume | 136,050 |
| 50-day MA | $4.34 | Dividend yield | N/A |
| 200-day MA | $9.40 | Market Cap | 1.38M |
SONN Stock Price Chart Interactive Chart >
Sonnet BioTherapeutics Holdings, Inc. (SONN) Company Bio
Sonnet BioTherapeutics Holdings, Inc. operates as a clinical stage biotechnology company. The Company develops fully human albumin binding technology that helps the development of innovative targeted biologic drugs with enhanced single-or bi-specific mechanisms. Sonnet BioTherapeutics Holdings serves customers in the United States.
SONN Price Returns
| 1-mo | -53.35% |
| 3-mo | -70.47% |
| 6-mo | -85.15% |
| 1-year | -83.17% |
| 3-year | -99.83% |
| 5-year | -99.99% |
| YTD | -85.49% |
| 2023 | -93.12% |
| 2022 | -80.12% |
| 2021 | -81.48% |
| 2020 | -85.46% |
| 2019 | -54.26% |
Loading social stream, please wait...